BACTERIA AGAINST VIRUSES: PROSPECTS OF BACTERIOPHAG THERAPY
DOI:
https://doi.org/10.37547/Keywords:
Bacteriophage, virus, antibiotic resistance, phage therapy, microbiome, infection, immunity, biotechnology, genetic engineering, medical innovation.Abstract
This article discusses the microbiological properties of bacteriophages - viruses that infect bacteria, their mechanisms of killing pathogenic bacteria, and the prospects for the use of bacteriophage therapy in medicine. Bacteriophages are becoming increasingly relevant as an alternative means of treating antibiotic-resistant bacteria. The article analyzes the types of bacteriophages, their mechanism of action, the results of clinical studies, and global scientific strategies.
Downloads
References
1. Abedon, S. T., García, P., Mullany, P., & Aminov, R. (2017). Phage therapy: Past, present and future. Frontiers in Microbiology, 8, 981. https://doi.org/10.3389/fmicb.2017.00981
2. Alavidze, Z., & Kutateladze, M. (2020). The Eliava Institute of Bacteriophages: 100 years of phage research and therapy. Virology Journal, 17(1), 137.
3. Brüssow, H. (2019). What is needed for phage therapy to become a reality in Western medicine?. Virology, 543, 62–68.
4. Chan, B. K., & Abedon, S. T. (2015). Bacteriophages and their enzymes in biofilm control. Current Opinion in Biotechnology, 31, 76–85.
5. Clokie, M. R. J., Kropinski, A. M., & Lavigne, R. (2021). Phages: Their role in bacterial pathogenesis and therapy. Annual Review of Virology, 8, 321–340.
6. Górski, A., Międzybrodzki, R., & Weber-Dąbrowska, B. (2018). Phage therapy: Combating infections with viruses. Annual Review of Microbiology, 72, 299–317.
7. Henein, A. (2013). What are the limitations on the wider therapeutic use of phage? Bacteriophage, 3(2), e24872.
8. Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019). Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host & Microbe, 25(2), 219–232.
9. Kutateladze, M., & Adamia, R. (2010). Phage therapy experience at the Eliava Institute. Medecine et Maladies Infectieuses, 40(11–12), 511–515.
10. Lin, D. M., Koskella, B., & Lin, H. C. (2017). Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World Journal of Gastrointestinal Pharmacology and Therapeutics, 8(3), 162–173.
11. Łobocka, M., Dąbrowska, K., & Górski, A. (2020). Bacteriophages and the modern medicine. Polish Journal of Microbiology, 69(1), 1–11.
12. Oechslin, F. (2018). Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses, 10(7), 351.
13. Pirnay, J. P., De Vos, D., & Verbeken, G. (2019). Phage therapy in the 21st century: Facing the challenge of antibiotic resistance. Clinical Microbiology Reviews, 32(2), e00012–19.
14. Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001). Bacteriophage therapy. Antimicrobial Agents and Chemotherapy, 45(3), 649–659.
15. World Health Organization (WHO). (2022). Global action plan on antimicrobial resistance. Geneva: WHO Press.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
